Deena M.A. Gendoo

引用先

	すべて	2020 年以来
引用	1990	1322
h 指標	17	16
i10 指標	24	20

280

140

210

2011201220132014201520162017201820192020202120222023202420255 8 7 13 18 82 125 173 219 268 280 279 246 227 22

オープンアクセス

すべて表示

29 件の論文

0 件の論文

利用可能

利用不可

助成機関の要件に基づく

共著者

Benjamin Haibe-KainsScientist (Principal Investigator), Princess Margaret Cancer Centre, University Health Network確認したメールアドレス: uhnresearch.ca
Levi WaldronCity University of New York Graduate School of Public Health and Health Policy確認したメールアドレス: sph.cuny.edu
Anna GoldenbergScientist, SickKids Research Institute; Assistant Professor Department of Computer Science, University of Toronto確認したメールアドレス: utoronto.ca
Paul M. HarrisonProfessor of Biology, McGill University確認したメールアドレス: mcgill.ca
Joel ParkerUniversity of North Carolina at Chapel Hill確認したメールアドレス: email.unc.edu
Mathieu Lupien, PhD; FRSCSenior Scientist/Professor, Princess Margaret Cancer Centre確認したメールアドレス: uhn.ca
Andrew H. BeckCo-Founder and CEO at PathAI確認したメールアドレス: PathAI.com
Markus S. SchröderETH Zürich確認したメールアドレス: biol.ethz.ch
Eldad ZacksenhausProfessor of Medicine, University of Toronto確認したメールアドレス: utoronto.ca
Heather SelbyStanford University確認したメールアドレス: stanford.edu
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtU確認したメールアドレス: dfci.harvard.edu
Patrick GrossmannPh.D. Candidate conducting research at Harvard Medical School, Dana-Farber Cancer Institute, BWH確認したメールアドレス: jimmy.harvard.edu
Sepehr EhsaniUniversity College London確認したメールアドレス: ucl.ac.uk
Gary BaderProfessor of Molecular Genetics and Computer Science, The Donnelly Centre, University of Toronto確認したメールアドレス: utoronto.ca
Ruth IsserlinDonnelly Centre, University of Toronto確認したメールアドレス: utoronto.ca
Robert Castelo (0000-0003-2229-4508)Associate Professor, Universitat Pompeu Fabra (ROR 04n0g0b29), Barcelona確認したメールアドレス: upf.edu
David Gomez-CabreroAssoc. Professor KAUST確認したメールアドレス: kaust.edu.sa
Aedin CulhaneUniversity of Limerick School of Medicine確認したメールアドレス: ul.ie
Sean DavisUniversity of Colorado確認したメールアドレス: cuanschutz.edu
Kasper D. HansenDepartment of Biostatistics, Johns Hopkins University確認したメールアドレス: jhsph.edu

フォロー

Deena M.A. Gendoo

Associate Professor in Computational Biology, University of Birmingham

確認したメールアドレス: bham.ac.uk - ホームページ

Bioinformatics Computational Biology Cancer Disease Models Pharmacogenomics


タイトル引用回数順公開年順タイトル順	引用先引用先	年
Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer DMA Gendoo, N Ratanasirigulchai, MS Schröder, L Paré, JS Parker, ... Bioinformatics 32 (7), 1097-1099, 2016	323	2016
PharmacoGx: an R package for analysis of large pharmacogenomic datasets P Smirnov, Z Safikhani, N El-Hachem, D Wang, A She, C Olsen, ... Bioinformatics 32 (8), 1244-1246, 2016	283	2016
Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ... Cancer cell 30 (6), 891-908, 2016	252	2016
CD73 is associated with poor prognosis in high-grade serous ovarian cancer M Turcotte, K Spring, S Pommey, G Chouinard, I Cousineau, J George, ... Cancer research 75 (21), 4494-4503, 2015	246	2015
Consensus on molecular subtypes of high-grade serous ovarian carcinoma GM Chen, L Kannan, L Geistlinger, V Kofia, Z Safikhani, DMA Gendoo, ... Clinical Cancer Research 24 (20), 5037-5047, 2018	137	2018
The molecular basis of breast cancer pathological phenotypes YJ Heng, SC Lester, GMK Tse, RE Factor, KH Allison, LC Collins, ... The Journal of pathology 241 (3), 375-391, 2017	126	2017
Medulloblastoma subgroups remain stable across primary and metastatic compartments X Wang, AM Dubuc, V Ramaswamy, S Mack, DMA Gendoo, M Remke, ... Acta neuropathologica 129, 449-457, 2015	102	2015
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer DMA Gendoo, RE Denroche, A Zhang, N Radulovich, GH Jang, M Lemire, ... PLoS computational biology 15 (1), e1006596, 2019	65	2019
Public data and open source tools for multi-assay genomic investigation of disease L Kannan, M Ramos, A Re, N El-Hachem, Z Safikhani, DMA Gendoo, ... Briefings in bioinformatics 17 (4), 603-615, 2016	61	2016
MetaGxData: clinically annotated breast, ovarian and pancreatic cancer datasets and their use in generating a multi-cancer gene signature DMA Gendoo, M Zon, V Sandhu, VSK Manem, N Ratanasirigulchai, ... Scientific reports 9 (1), 8770, 2019	44	2019
A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling DY Wang, DMA Gendoo, Y Ben-David, JR Woodgett, E Zacksenhaus Breast cancer research 21, 1-13, 2019	43	2019
Integrative cancer pharmacogenomics to infer large-scale drug taxonomy N El-Hachem, DMA Gendoo, LS Ghoraie, Z Safikhani, P Smirnov, ... Cancer research 77 (11), 3057-3069, 2017	41	2017
The first small-molecule inhibitors of members of the ribonuclease E family L Kime, HA Vincent, DMA Gendoo, SS Jourdan, CWG Fishwick, ... Scientific reports 5 (1), 8028, 2015	34	2015
Discordant and chameleon sequences: their distribution and implications for amyloidogenicity DMA Gendoo, PM Harrison Protein Science 20 (3), 567-579, 2011	34	2011
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy PED Chung, DMA Gendoo, R Ghanbari-Azarnier, JC Liu, Z Jiang, J Tsui, ... Nature communications 11 (1), 1825, 2020	33	2020
PrionHome: a database of prions and other sequences relevant to prion phenomena D Harbi, M Parthiban, DMA Gendoo, S Ehsani, M Kumar, G Schmitt-Ulms, ... PloS one 7 (2), e31785, 2012	32	2012
Administration of hypoxia-activated prodrug evofosfamide after conventional adjuvant therapy enhances therapeutic outcome and targets cancer-initiating cells in preclinical … J Haynes, TD McKee, A Haller, Y Wang, C Leung, DMA Gendoo, ... Clinical Cancer Research 24 (9), 2116-2127, 2018	24	2018
The anti-tumour activity of DNA methylation inhibitor 5-aza-2′-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress HJ Gleneadie, AH Baker, N Batis, J Bryant, Y Jiang, SJH Clokie, ... Cancer letters 501, 172-186, 2021	16	2021
Personalized diagnosis of medulloblastoma subtypes across patients and model systems DMA Gendoo, P Smirnov, M Lupien, B Haibe-Kains Genomics 106 (2), 96-106, 2015	14	2015
The landscape of the prion protein's structural response to mutation revealed by principal component analysis of multiple NMR ensembles DMA Gendoo, PM Harrison Public Library of Science 8 (8), e1002646, 2012	14	2012

現在システムで処理を実行できません。しばらくしてからもう一度お試しください。

論文 1–20

年間引用数

重複した引用

結合された引用

共著者を追加共著者

フォロー

引用先

共著者